

Indication | MeSH | Ontology | ICD-10 | PhĀ 1 | PhĀ 2 | PhĀ 3 | PhĀ 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Glioblastoma | D005909 | EFO_0000515 | ā | 5 | 2 | 1 | ā | ā | 6 |
Indication | MeSH | Ontology | ICD-10 | PhĀ 1 | PhĀ 2 | PhĀ 3 | PhĀ 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Glioma | D005910 | EFO_0000520 | ā | 6 | 3 | ā | ā | ā | 6 |
| Astrocytoma | D001254 | EFO_0000271 | ā | 5 | 2 | ā | ā | ā | 5 |
| Recurrence | D012008 | ā | ā | 1 | 1 | ā | ā | ā | 1 |
Indication | MeSH | Ontology | ICD-10 | PhĀ 1 | PhĀ 2 | PhĀ 3 | PhĀ 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Carcinoma | D002277 | ā | C80.0 | 1 | ā | ā | ā | ā | 1 |
| Adrenocortical carcinoma | D018268 | ā | ā | 1 | ā | ā | ā | ā | 1 |
| Oligodendroglioma | D009837 | EFO_0000631 | ā | 1 | ā | ā | ā | ā | 1 |
| Drug common name | Cintredekin besudotox |
| INN | cintredekin besudotox |
| Description | Cintredekin besudotox is a protein pharmaceutical. It is currently being investigated in clinical studies. |
| Classification | Protein |
| Drug class | interleukins |
| Image (chem structure or protein) | ![]() |
| Structure (InChI/SMILES or Protein Sequence) | ā |
| PDB | ā |
| CAS-ID | ā |
| RxCUI | ā |
| ChEMBL ID | CHEMBL2108583 |
| ChEBI ID | ā |
| PubChem CID | ā |
| DrugBank | ā |
| UNII ID | ZL04JX89M7 (ChemIDplus, GSRS) |
